Revenio Group Corporation | Stock Exchange Release | May 29, 2026 at 09:45:00 EEST
A total of 2,485,797 new shares issued in the share issue directed to Visionix shareholders, as announced by Revenio Group Corporation on 28 May 2026, have been registered today, 29 May 2026, in the Finnish Trade Register. After the registration of the new shares, Revenio has a total of 29,166,913 shares.
The new shares will confer equal rights to the company’s existing shares from the date of registration.
The new shares will be admitted to trading on Nasdaq Helsinki Ltd’s main list approximately from June 1, 2026 onwards.
For further information, please contact
CEO Jouni Toijala, tel. +358 484 0085
jouni.toijala@revenio.fi
Distribution
Nasdaq Helsinki Oy
Financial Supervisory Authority (FIN-FSA)
Main media
www.reveniogroup.fi/en
Revenio Group in brief
Revenio is a leading turnkey solutions provider in the global eye care market. The group offers fast, user-friendly, and reliable tools for diagnosing a wide variety of eye diseases. Revenio’s solutions include e.g. tonometers, fundus imaging devices, optical coherence tomography (OCT), perimeters, multimodal devices, refraction systems, and software solutions under iCare and Visionix.
In May 2026, Revenio joined forces with Visionix, creating the most innovative, creative and comprehensive entity serving eye care professionals across optometry, optical retail and ophthalmology. In 2025, the Group’s net sales totaled EUR 109.7 million, with an operating profit of EUR 25.4 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.